176 related articles for article (PubMed ID: 35469480)
1. Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review.
Sun Y; Chang W; Yao J; Liu H; Zhang X; Wang W; Zhao K
J Int Med Res; 2022 Apr; 50(4):3000605221091095. PubMed ID: 35469480
[TBL] [Abstract][Full Text] [Related]
2. Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Yoshizawa J; Ishizone S; Ikeyama M; Nakayama J
BMC Cancer; 2017 May; 17(1):368. PubMed ID: 28545511
[TBL] [Abstract][Full Text] [Related]
3. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.
Gao YB; Zhang DF; Jin XL; Xiao JC
J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131
[TBL] [Abstract][Full Text] [Related]
4. Α-fetoprotein producing hepatoid gastric adenocarcinoma with neuroendocrine differentiation: A case report.
Li T; Liu T; Wang M; Zhang M
Medicine (Baltimore); 2018 Sep; 97(37):e12359. PubMed ID: 30212993
[TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein-producing hepatoid gastric adenocarcinoma in a child presenting with spontaneous gastric perforation.
Emir S; Karakurt N; Karakuş E; Şenel E; Kırsaçlıoğlu C; Demir HA; Orhan D
Turk J Pediatr; 2014; 56(1):88-91. PubMed ID: 24827954
[TBL] [Abstract][Full Text] [Related]
6. Alpha-Fetoprotein (AFP)-Negative Hepatoid Adenocarcinoma of the Stomach and its Associated Uncommon Features With a Review.
Rajasekaran P; Pattnaik B; Mishra M; Shahin M; Mishra P; Ayyanar P
Int J Surg Pathol; 2023 Aug; 31(5):872-878. PubMed ID: 36503302
[TBL] [Abstract][Full Text] [Related]
7. Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a Case.
Nuevo-Gonzalez JA; Cano-Ballesteros JC; Lopez B; Andueza-Lillo JA; Audibert L
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S28-31. PubMed ID: 21826411
[TBL] [Abstract][Full Text] [Related]
8. [A case of liver metastasis of gastric hepatoid adenocarcinoma].
Jeong EH; Kim DH; Ma SH; Chung EJ; Bae SS; Park AY; Chu HJ
Korean J Hepatol; 2009 Jun; 15(2):201-8. PubMed ID: 19581772
[TBL] [Abstract][Full Text] [Related]
9. Hepatoid adenocarcinoma of the stomach: case report and short notes on immunohistochemical markers.
Augustin G; Jelincic Z; Tentor D; Majerovic M; Matosevic P
Acta Gastroenterol Belg; 2009; 72(2):253-6. PubMed ID: 19637784
[TBL] [Abstract][Full Text] [Related]
10. Primary hepatocellular carcinoma and hepatoid adenocarcinoma of the stomach with liver metastasis: an unusual association.
Morinaga S; Takahashi Y
Jpn J Clin Oncol; 1996 Aug; 26(4):258-63. PubMed ID: 8765186
[TBL] [Abstract][Full Text] [Related]
11. Hepatoid adenocarcinoma of stomach: case report of a rare histological variant.
Mahajan V; Gupta N; Gupta S; Sharma R
Indian J Pathol Microbiol; 2014; 57(1):116-9. PubMed ID: 24739848
[TBL] [Abstract][Full Text] [Related]
12. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA.
Supriatna Y; Kishimoto T; Uno T; Nagai Y; Ishikura H
Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893
[TBL] [Abstract][Full Text] [Related]
13. Hepatoid adenocarcinoma of the stomach.
Inagawa S; Shimazaki J; Hori M; Yoshimi F; Adachi S; Kawamoto T; Fukao K; Itabashi M
Gastric Cancer; 2001; 4(1):43-52. PubMed ID: 11706627
[TBL] [Abstract][Full Text] [Related]
14. Solitary AFP- and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
Iso Y; Sawada T; Shimoda M; Rokkaku K; Ohkura Y; Kubota K
Hepatogastroenterology; 2005; 52(66):1930-2. PubMed ID: 16334809
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic characteristics and prognosis of gastric hepatoid adenocarcinoma].
Zhao R; Wang X; Lan X; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1035-1039. PubMed ID: 28900996
[TBL] [Abstract][Full Text] [Related]
16. [AFP-producing gastric cancer and hepatoid gastric cancer].
Wang YK; Zhang XT
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):801-807. PubMed ID: 29151285
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and prognosis of hepatoid adenocarcinoma of the stomach].
Yao L; Xu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Feb; 17(2):196-200. PubMed ID: 24577778
[TBL] [Abstract][Full Text] [Related]
18. Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.
Ahn JS; Jeon JR; Yoo HS; Park TK; Park CK; Sinn DH; Paik SW
Clin Mol Hepatol; 2013 Jun; 19(2):173-8. PubMed ID: 23837142
[TBL] [Abstract][Full Text] [Related]
19. Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma.
Li W; Li Q; Yu Y; Wang Y; Chen E; Chen L; Wang Z; Cui Y; Liu T
Cancer Manag Res; 2020; 12():11113-11119. PubMed ID: 33173344
[TBL] [Abstract][Full Text] [Related]
20. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
